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Behavioral/Cognitive
Scopolamine Impairs Appetitive But Not Aversive Trace
Conditioning: Role of the Medial Prefrontal Cortex
Marie-Astrid Pezze, Hayley J. Marshall, and Helen J. Cassaday
School of Psychology, University of Nottingham, Nottingham NG7 2RD, United Kingdom
The muscarinic acetylcholine receptor is an important modulator of medial prefrontal cortex (mPFC) functions, such as the working
memory required to bridge a trace interval in associative leaning. Aversive and appetitive trace conditioning procedures were used to
examine the effects of scopolamine (0.1 and 0.5mg/kg, i.p.) inmale rats. Follow-up experiments tested the effects ofmicroinfusionof 0.15
g of scopolamine (0.075g of in 0.5l/side) in infralimbic (IL) versus prelimbic regions of ratmPFC, in appetitive trace and locomotor
activity (LMA)procedures. Systemic scopolaminewaswithout effect in anaversive trace conditioningprocedure, but impairedappetitive
conditioning at a 2 s trace interval. This effectwas demonstrated as reduced respondingduringpresentations of the conditioned stimulus
(CS) and during the interstimulus interval (ISI). There was no such effect on responding during food (unconditioned stimulus, US)
responding or in the intertrial interval (ITI). In contrast, systemic scopolamine dose-relatedly increased LMA. Trace conditioning was
similarly impaired at the 2 s trace (shown as reduced responding to the CS and during the ISI, but not during US presentations or in the
ITI) after infusion in mPFC, whereas LMA was increased (after infusion in IL only). Therefore, our results point to the importance of
cholinergic modulation in mPFC for trace conditioning and show that the observed effects cannot be attributed to reduced activity.
Key words: appetitive; conditioned emotional response; medial prefrontal cortex; rat; scopolamine; trace conditioning
Introduction
Trace conditioning procedures examine the ability to associate a
conditioned stimulus (CS, e.g., noise) with an unconditioned
stimulus (US, e.g., foot shock or food) across an intervening time
interval between these events (Pavlov, 1927). This ability relies on
an aspect of working memory necessary for the maintenance of
information “online” before encoding (Goldman-Rakic and
Brown, 1981; Miller et al., 1996; Levy and Goldman-Rakic, 2000;
Curtis and D’Esposito, 2003). In delay conditioning, the CS may
be of relatively long duration, but there is no time gap betweenCS
offset andUS delivery, so the demand onworkingmemory is less.
Trace conditioning, but not delay conditioning, is impaired by a
number of drug treatments, including the use of the muscarinic
acetylcholine (ACh) antagonist scopolamine in eye-blink (Kaneko
and Thompson, 1997), fear conditioning (Hunt and Richardson,
2007), and appetitive procedures (Seager et al., 1999).
Medial prefrontal cortex (mPFC) has been identified as a key
neural substrate of trace conditioning (Kronforst-Collins and Dis-
terhoft, 1998; Weible et al., 2000, 2003; McLaughlin et al., 2002;
Takehara-Nishiuchi et al., 2005) and there is evidence to suggest that
the muscarinic ACh receptor is a modulator of this aspect of mPFC
function from (850 ms trace) eye blink (Chen et al., 2014) and ap-
petitive (10 s trace) procedures (Flesher et al., 2011).
The ability to associate stimuli over trace intervals and thus
link discontiguous events has been argued to reflect temporal
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Significance Statement
Events are very often separated in time, in which case working memory is necessary to condition their association in “trace
conditioning.” The present study used conditioning variantsmotivated aversively with foot shock and appetitively with food. The
drug scopolamine was used to block muscarinic acetylcholine receptors involved in working memory. The results show that
reduced cholinergic transmission inmedial prefrontal cortex (mPFC) impaired appetitive trace conditioning at a 2 s trace interval.
However, scopolamine was without effect in the aversive procedure, revealing the importance of procedural differences to the
demonstration of the drug effect. The finding that blockade of muscarinic receptors in mPFC impaired trace conditioning shows
that these receptors are critical modulators of short-term working memory.
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information processing, an aspect of relational learning that rep-
resents a key component of working memory (Sweatt, 2004).
Consistent with the validity of the behavioral model, trace con-
ditioning declines with normal aging in a number of species from
rats (McEchron et al., 2004; Moyer and Brown, 2006) to humans
(Knuttinen et al., 2001; Cheng et al., 2010). The cholinergic sys-
tem remains an important focus of aging research (Levey, 1996;
Davis et al., 2010) and, although scopolamine has acknowledged
limitations as a research tool, it is still widely held to provide a
valid pharmacological model of age-related cognitive impair-
ment (Hasselmo and Sarter, 2011).
To our knowledge, there has been no examination of the role
of scopolamine in mPFC at longer trace intervals and no system-
atic comparison of its effects on trace conditioning in aversive
and appetitive test variants (Cassaday et al., 2005; Pezze et al.,
2015, 2016). Within mPFC, distinct subregions are distinguish-
able on the basis of their differing patterns of interconnectivity
(Fisk and Wyss, 1999; Heidbreder and Groenewegen, 2003;
Vertes, 2004). Moreover, there is also electrophysiological evi-
dence for functional differentiation between prelimbic (PL) and
infralimbic (IL) neuronal activity measured during trace condi-
tioning at a 20 s trace interval (Gilmartin and McEchron, 2005;
Gilmartin et al., 2014).
Experiment 1 of the present study used an established condi-
tioned emotional response (CER) trace procedure (Norman and
Cassaday, 2003; Nelson et al., 2012; Pezze et al., 2016) with an
extended delay conditioning control group and a relatively short
trace interval (Hunt and Richardson, 2007; Baysinger et al.,
2012). Specifically, a 10 s CS was presented with or without an
equivalent 10 s trace interval as the first step to determine
whether any sensitivity to the effects of systemic scopolamine
could be demonstrated.
Experiment 2 examined the effects of systemic scopolamine
over two trace intervals in an established appetitive procedure in
which conditioning has been shown previously to be reduced at a
2 s trace interval after treatment with SKF81297, both systemic
and intra-mPFC (Pezze et al., 2015). Experiment 3 tested the
effects of the same scopolamine doses on locomotor activity
(LMA). Experiment 4 went on to examine the effects of scopol-
amine administered bymicroinfusion into PL and ILmPFC sub-
regions at the same coordinates used to examine the role of the
dopamine D1 receptor agent SKF81297 (Pezze et al., 2015) and
using the trace conditioning variant shown sensitive to the effects
of systemic scopolamine in Experiment 2 of the present study.
Materials andMethods
Subjects
Seventy-two experimentally naive male Wistar rats were used in Experi-
ments 1 and 2 (Charles River Laboratories; weights on arrival in the range
of 153–206 g and 151–184 g in Experiments 1 and 2, respectively). Allo-
cations to experimental groups were random. One of the rats to be used
in Experiment 2 (allocated to the saline 2 s trace group) was humanely
killed for reasons unrelated to the experimental procedure. Experiment 3
tested 33 rats (at 320–405 g, counterbalanced for previous experimental
group). Throughout the experiments, rats were housed four per cage on
a 12:12 h dark/light cycle and received ad libitum food andwater (upuntil
24 h before shaping, see below). After arrival, each rat was handled for
10min per day over the course of 1week.During this time, rats reached
mean weight 200 g before the start of any water or food restriction or
implantation of cannulae. Experiment 4 used in total 72 rats (operated in
the range 277–315 g). Two rats died during surgery due to complications
under anesthesia; six were humanely killed because of postoperative
complications (two had suspected meningitis; four showed nonspecific
signs that might have developed to exceed the moderate severity band-
ing). Synulox was therefore administered subcutaneously (0.05 ml/kg) as a
prophylacticmeasure. Behavioral testing took place after a (minimum) 11 d
recovery period. Experiment 5 required 24 of the implanted rats (now at
393–546 g, counterbalanced for previous experimental group).
All procedures were performed in accordance with the principles of
laboratory animal care, specifically theUKAnimals Scientific Procedures
Act of 1986 (Project License PPL 40/3716).
Behavioral apparatus
The conditioning boxes have been fully described previously (Norman
and Cassaday, 2003; Nelson et al., 2012; Pezze et al., 2016). In the Exper-
iment 1CERprocedure, awaterspoutwasmounted on 1wall, 5 cm above
the floor and connected to a lickometer supplied by a pump. The CS
was a 10 s mixed-frequency (80 dB) noise presented at a 0 or 10 s trace
interval. Foot shock of 1 s duration and 1 mA intensity provided the US
(pulsed voltage: output square wave 10 ms on, 80 ms off, 370 V peak
under no load conditions; MISAC Systems).
In Experiments 2 and 4, otherwise identical conditioning boxes were
adapted for appetitive conditioning (for further details, see Pezze et al.,
2015). Nose pokes to the foodmagazinewere recorded by the breaking of
the photobeamwithin the foodmagazine. TheUSwas two 45mg sucrose
pellets dispensed into the magazine (Formula F; Noyes Precision Food).
The CS was a 72 dB mixed-frequency noise of 5 s duration. In both
aversive and appetitive-conditioning procedures, an experimental back-
ground stimuluswas provided by 3wall-mounted stimulus lights and the
house light flashing on (0.5 s) and off (0.5 s), continuously for the dura-
tion of the conditioning session.
In Experiments 3 and 5, LMAwas measured in a dimly lit (50–70 lux)
room in 11 clear Perspex chambers (Photobeam Activity System; San
Diego Instruments) as described previously (Jones et al., 2011; Pezze et
al., 2015). Two consecutive breaks of adjacent beams within the lower
level of photobeams generated a locomotor count.
Experiments 1–3: systemic injections
Systemic scopolamine doses were based on those found previously to be
effective in a trace fear conditioning procedure (Hunt and Richardson,
2007). Scopolamine (Tocris Bioscience) was dissolved in saline (0.9%
NaCl) to provide an injection volume of 1ml/kg. In Experiments 1 and 2,
scopolamine (0.1 and 0.5 mg/kg) or saline was injected intraperitoneally
15 min before conditioning sessions. There was one such session in Ex-
periment 1 (Fig. 1A). The plasma half-life of scopolamine in the rat is
20 min (Lyeth et al., 1992) and the strength of conditioning to the
experimental stimuli was tested drug-free on subsequent days of the
procedure. There were 4 conditioning sessions and thus 4 d of injections
in Experiment 2: conditioning was examined both on the baseline and in
follow-up drug-free extinction tests (Fig. 2A). In Experiment 3, rats were
immediately replaced in the LMA apparatus to document the onset and
course of the scopolamine treatments effects.
Experiments 4 and 5: microinfusions in the mPFC
Rats were anesthetized using isoflurane delivered in oxygen (induction:
4–5%; maintenance: 1–3%) and secured in a stereotaxic frame. Bilateral
infusion guide cannulae (the “mouse” model C235GS-5–1.2; Plastics One)
were implanted through small holes drilled in the skull. The tips of the guide
cannulae were aimed 0.5mmabove the injection sites in the PL or IL subre-
gion of mPFC. The coordinates for PL were 3 mm anterior and0.6 mm
lateral from bregma and 4.0 mm ventral from the skull surface; the coordi-
nates for ILwere3mmanterior and0.6mmlateral frombregmaand5.0
mmventral from the skull surface (for further details, see Pezze et al., 2015).
Cannulae were secured to the skull with dental acrylic and stainless-steel
screws.Double stylets (33 gauge; PlasticsOne)were inserted and closedwith
a dust cap. During the recovery period, rats were checked daily and habitu-
ated to the manual restraint necessary for the scopolaminemicroinfusions.
The doses of scopolamine used for the microinfusions were based on
those found previously to be effective in tests of working memory (Gra-
non et al., 1995; Chudasama et al., 2004; Barker and Warburton, 2009).
Rats were gently restrained and 33-gauge injectors (Plastics One) were
inserted into the guides. The injector tips extended 0.5 mm below the
guides into the PL or IL mPFC and the injector ends were connected
through polyethylene tubing to 5 l syringes mounted on a microinfu-
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sion pump (for further details, see Pezze et al., 2015). A volume of 0.5
l/side of 0.9% saline or of scopolamine in saline was then infused bilat-
erally over 1 min. The solution used was dissolved at a concentration of
0.15 g/l and then aliquoted and kept frozen until use (in the present
study, not longer than 3 weeks) at a dose of 0.075 g of scopolamine per
side, in total 0.15 g per rat. In Experiment 4, the conditioning session
started 10min after the infusion. There were 4 conditioning sessions and
thus 4 d of infusions in Experiment 4: conditioning was examined both
on the baseline and in follow-up drug-free extinction tests (Fig. 2A). In
Experiment 5, rats were immediately replaced in the LMA apparatus to
document the onset and course of the effects of scopolamine infusion.
Experiment 1: CER trace conditioning procedure
Water restriction was introduced 1 d before shaping and there was 1 h ad
libitum access to water in their home cage after each of the procedural
stages outlined below. Rats were trained, conditioned, and tested after
Figure 1. Conditioned suppression to the noise CS in 0 and 10 s conditioned groups after conditioning under saline (Sal) or after systemic (i.p.) treatment with scopolamine at 0.1 mg/kg (Scop
0.1 mg/kg) or 0.5 mg/kg (Scop 0.5 mg/kg) in Experiment 1. Error bars indicate SEM. A, Timeline illustrating the experimental procedures (1 d of conditioning under scopolamine) leading up to the
drug-free tests of conditioned suppression. B, Mean suppression ratios. C, Mean number of licks in the first 1 min of the noise test.
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20–23 h of water restriction (fully described previously: Norman and
Cassaday, 2003; Nelson et al., 2012; Pezze et al., 2016).
Preconditioning to establish baseline lick responses. Rats were shaped to
drink from the waterspout over 2 d. There then followed 5 d of pretrain-
ing, inwhich each rat drank in its allocated conditioning boxes for 15min
each day (timed from first lick). The licking spout was illuminated
throughout, but no other stimuli were presented.
Conditioning with foot shock. No water was available within the boxes
and the waterspouts were not illuminated. The US foot shock was deliv-
ered following termination of the CS in each of two conditioning trials
per conditioning session (of which there were two). The first pairing of CS
and US was presented after 5 min had elapsed and the second pairing was 5
min after the first, followed by a further 5 min left in the apparatus. In the
traceconditionedgroup, therewasa10s interstimulus interval (ISI)between
the noise (CS) and foot shock (US). In the delay-conditioned control group,
there was no interval between the CS and US (0 s ISI). The flashing light
experimental background was presented for the duration of the condition-
ing session within which the two conditioning trials took place. In the ab-
sence of licking, there were no behavioral measures to record.
Reshaping after foot shock.On the day after conditioning, animals were
reshaped, drug free, and following the same procedure as in the precon-
ditioning sessions. This both reestablished licking after conditioning and
Figure 2. Mean nose pokes are shown as a function of the 4 d of conditioning (D3–D6) for the 5 s of the ITI just before CS presentation (Pre-CS) compared with during the 5 s CS presentation or
in the 5 s post-CS when food was delivered (US). Error bars indicate SEM. A, Timeline illustrating the experimental procedures including the 4 d of conditioning under scopolamine. B, Diamonds
denote rats conditionedat the10 s trace interval and circlesdenote rats conditionedat the2 s trace interval after systemic treatmentwith scopolamine (i.p.) at 0.1mg/kg (gray fill) or 0.5mg/kg (black
fill) in Experiment2.Control rats (white fill)were injectedwithsaline.Asterisks indicateasignificantdifferencebetweensalineandscopolamine-injected2stracegroupswith*p0.05,**p0.01.Hashsigns
indicatea significantdifferencebetweenthe0.5mg/kg-10sandSal-10sgroups,###p0.001.C, Diamondsdenote rats conditionedat the10s trace interval andcirclesdenote rats conditionedat the2s trace
interval after scopolamine infusion (0.075g in0.5l/side) inPL (gray fill) or IL (black fill) in Experiment4. Control rats (white fill)were injectedwith saline inPLor IL. Asterisk indicates a significantdifference
between saline and scopolamine-infused 2 s trace groupswith *p 0.05. Hash sign indicates a significant difference between the IL-2 s and Sal-2 s groups, #p 0.05.
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provided a measure of contextual conditioning, reflected in the extent to
which licking was suppressed in the conditioning boxes.
CER tests. Conditioned suppression to the CS and flashing light back-
ground stimulus was tested drug free and in a counterbalanced order. On
the first test day, 24 h after reshaping and 48 h after conditioning, the
animals were placed in the conditioning boxes and presented with the
noise CS or flashing light background stimulus. Water was available
throughout the test and the waterspout was illuminated. Once the ani-
mals had made 50 licks, the CS was presented for 15 min. On the second
test day, 72 h after conditioning, the alternate flashing lights background
or noise CS was presented after 50 licks and continued for 15 min. The
latency to make 50 licks in the absence of the stimulus (A period) was
compared with the time taken to complete 50 licks following stimulus
onset (B period) in a suppression ratio: A/(A B).
Experiment 2: appetitive trace conditioning procedure
Onedaybefore shaping, foodwas removed in themorning and the ratswere
introduced to sucrose pellets in the home cage later the same day before
being fed standard laboratory chow rationed at 5 g/100 g body weight. This
level of food restriction was continued for the duration of the appetitive
conditioning procedure (fully described previously: Pezze et al., 2015).
Preconditioning.Ratswere shaped to take reward pellets from themag-
azine. Then followed 2 d of baseline sessions, during which there were 30
unsignaled rewards (each of 2 sucrose pellets) over 60min delivered on a
variable interval of2 min.
Conditioning. There were 4 d of conditioning at 30 trials per day,
delivered within 60 min conditioning sessions. Depending on the exper-
imental group, the reward (US) was delivered 2 or 10 s after CS offset (in
the 2 different trace groups). On each conditioning day, 30 signaled
rewards were presented on a variable interval. Continuous presentation
of the background stimulus (flashing lights) also encompassed the 2 or
10 s ISI. The ISI added to the overall duration so that conditioning sessions
lasted 61or 65min in total. Extinction tests of conditioning to theCS (noise)
and experimental background (flashing lights) stimuli were conducted in a
counterbalanced order; 24–48 h after conditioning procedures had been
completed. Ineachcase, therewere305spresentationsof the stimulusunder
test over the course of a 60 min session. The number of nose pokes in the
different components of the session was recorded.
Experiments 3 and 5: locomotor activity procedure
On the day before the LMA tests, each rat was habituated to its allocated
activity chamber for 30min (drug free). On the test day, there was a further
30 min habituation. Each rat was then removed for systemic injection or
microinfusion with scopolamine or saline and then replaced in the allo-
cated activity chamber. Total locomotor counts were recorded for each
consecutive 10 min epoch for a further 60 min. In Experiment 3, LMA
was reassessed in the same way 24 h later over the course of a 30 min test
session to determine whether the systemic scopolamine treatments had
any residual effects on LMA at this interval.
Design and analysis
Experiments 1, 2, and 4 each had 6 experimental groups run in 2  3
factorial designs: trace condition (at levels 0 or 10 s in Experiment 1, and
2 or 10 s in Experiments 2 and 4) and drug at levels (saline, 0.1, or 0.5
mg/kg scopolamine in Experiments 1–3; saline, IL, or PL scopolamine in
Experiments 4 and 5). In Experiment 1, the dependent variables were
drink latencies from the preconditioning day and the number of licks
made during the first 1 min of the 15 min session (min-1 licks) to check
for differences by experimental condition-to-be, reshaping drink laten-
cies and min-1 licks to assess contextual conditioning to the box cues,
suppression ratios and min-1 licks to assess the levels of conditioning to
the CS and experimental background stimulus.
In Experiments 2 and 4, the dependent variable was in each case the
number of nose pokes into the food magazine and there was an addi-
tional repeated-measures factor of days (at four levels). The strength of
associative learning was measured as responding during the 5 s presen-
tation of the CS. Significant three-way interactions were followed up by
simple main-effects analyses and further post hoc tests were by Fisher’s
LSD test. To compare effects on motivation for food reward or motor
responding, similar analyses were conducted on responding during the
5 s inwhich theUSwas delivered and on ITI responding in the remainder
of the session (excluding the ISI).
In addition, the responding of the animals during the trace interval be-
tween CS offset and US delivery was also examined separately for the 2 and
10 s conditioned groups because the intervals in use were not directly com-
parable.Moreover, the 10 s ISIwasbrokendown into5 (2 s) bins of time and
analyzed using repeated-measures ANOVAs by bins and days. Finally, ex-
tinction day test results were examined using the same between-subjects
design.
In Experiments 3 and 5, the LMA data were analyzed in blocks of 10
min at 3 levels for the test day habituation, 6 levels under drug, and 3
levels for the test of residual drug action conducted 24 h later on the
following day in Experiment 3. Post hoc tests were by Fisher’s LSD test.
Results
Experiment 1: systemic scopolamine in the CER procedure
Preconditioning: baseline licking
Min-1 licks were very closely matched across the experimental
conditions-to-be (in the range of 252–281 18 licks). Statistically,
there were no effects of trace or drug condition-to-be (maximum
F(2,66)2.137,p0.126 for the interactiononthe latencymeasure).
Reshaping: contextual conditioning
There was amain effect of drug on the latency to start drinking at
reshape (F(2,66) 3.553, p 0.034). This arose because rats pre-
viously conditioned under scopolamine took less time to start
drinking at reshape than those previously conditioned under sa-
line. This difference was significant after scopolamine at 0.5
mg/kg (p  0.014) and marginal at 0.1 mg/kg (p  0.050). No
other effects were significant (maximum F(1,66)  2.945, p 
0.091) for the main effect of trace on the reshape latency.
CER tests: CS (noise)
There was a main effect of trace on both the suppression ratio (Fig.
1B) and the min-1 licks measure (minimum F(1,66)  7.168, p 
0.009; Fig. 1C). However, there was no effect of drug (all F 1).
CER tests: experimental background (flashing lights)
There was no effect of trace (both F  1) and no effect of drug
(maximum F(2,66) 1.020, p 0.366) on the suppression ratio.
Experiment 2: systemic scopolamine in the
appetitive procedure
ITI responding
ANOVAofmagazine activity between conditioning trials showed
no effects of trace or drug (maximum F(2,65) 2.092, p 0.132).
Figure 2Ba shows the 5 s ITI just preceding the 5 s CS presenta-
tions for direct comparisonwith subsequent CS andUS respond-
ing. As can be seen in the figure, the response rates in the 5 s ITI
immediately pre-CS were very low and unsuitable for ANOVA.
CS responding
Therewere significantmain effects of both trace (F(1,65) 63.104,
p  0.001) and drug (F(2,65)  13.339, p  0.001). Importantly,
the three-way interaction among days, trace, and drug was signif-
icant (F(6,195) 3.155, p 0.006) and was also significant in the
linear trend (F(2,65) 5.516, p 0.006), so the rate of acquisition
depended on the rats’ drug group and on the trace interval in use.
Figure 2Bb shows depressed acquisition in the 2 s trace conditioned
groups treated with scopolamine. Follow-up analysis confined to
the 2 s trace group confirmed the effect of drug (F(2,32) 9.158,
p 0.001). CS responding was reduced under scopolamine com-
paredwith saline over the 4 consecutive days of conditioning (day
1: F(2,32) 5.605, p 0.008; saline vs 0.1mg/kg, p 0.004; saline
vs 0.5 mg/kg, p 0.008; day 4: F(2,32) 10.223, p 0.001; saline
vs 0.1 mg/kg, p  0.013; saline vs 0.5 mg/kg, p  0.0001). Al-
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though analysis confined to the 10 s trace group also showed a
significant main effect of drug (F(2,33)  3.969, p  0.028), this
effect was restricted to a decrease in the number of nose pokes on
day one after injection of 0.5mg/kg scopolamine (F(2,33) 8.542,
p 0.001; saline vs 0.5 mg/kg, p 0.001).
US responding
In contrast to the results seen on CS responding, there were no
overall effects of trace or drug (maximum F(1,65)  2.107, p 
0.151). The US responding showed some fluctuation over the
course of acquisition (F(3,195) 3.404, p 0.019). The only sig-
nificant effect of drug was seen in interaction with days in the
linear trend (F(2,65) 3.268, p 0.044) because of increased US
responding in scopolamine groups (Fig. 2Bc).
ISI responding: 2 s trace group
As would be expected, responding in the ISI increased over the
course of acquisition, which was confirmed statistically by the
main effect of days (F(3,96) 49.279, p 0.001) and in the linear
trend (F(1,32)  99.695, p  0.001). Consistent with the effects
seen on CS responding, there was both a main effect of drug
(F(2,32) 14.181, p 0.001) and an interaction between days and
drug (F(6,96) 4.035, p 0.001), whichwas also significant in the
linear trend (F(2,32) 7.010, p 0.003). Treatment with scopol-
amine depressed ISI responding in a dose-related fashion and the
increase in responding over days was less steep (Table 1).
ISI responding: 10 s trace group
The use of a longer trace interval made no difference to the pat-
tern of effects in the ISI; the results were entirely consistent with
those seen in the 2 s trace group. There was a main effect of days
(F(3,396)  7.958, p  0.001), which was also significant in the
linear trend (F(1,33) 12.677, p 0.001). There was again amain
effect of drug (F(2,33)  7.729, p  0.002) and an interaction
between days and drug (F(6,396)  5.584, p  0.001), which was
also significant in the linear trend (F(2,33)  8.505, p  0.001).
Treatment with scopolamine overall reduced ISI responding and
the increase in responding over days was depressed (Table 1).
None of the effects involving bins was significant.
Extinction tests
Consistent with the pattern of effects seen in acquisition, analyses
of the noise extinction tests revealed a main effect of trace in the
5 s post CS (F(1,65) 4.730, p 0.033) because of generally higher
responding in the 2 s conditioned groups. An effect of trace in the
ITI (F(1,65)  6.837, p  0.011) arose because of generally higher
responding in the 10 s conditioned groups. The effect of previous
drug treatment also carried over to extinction (F(2,65) 16.599, p
0.001), seen as overall reduced responding in the 5 s post CS. There
was no effect of trace or drug on anymeasure in the light extinction
tests (maximum F(1,65) 3.105, p 0.083, for ITI responding).
Experiment 3: systemic scopolamine and locomotor activity
LMA levels were well matched before any drug treatment and this
was confirmed by analysis of the 30 min habituation session. There
wasno effect of drug condition-to-be, either overall or in interaction
with blocks, both F 1 (Fig. 3A). Over the 90 min after drug treat-
ments, there was a clear main effect of drug (F(2,30)  5.531, p 
0.009). Scopolamine increased LMA in a dose-related fashion. The
difference between rats injectedwith saline versus 0.1mg/kg scopol-
amine was not significant (p  0.112), so the main effect can be
attributed to the difference between rats injected with saline versus
0.5 mg/kg scopolamine (p 0.002). Moreover, there was an inter-
actionbetweendrug andblocks (F(16,240)1.906,p0.021),which
was also significant in the linear trend (F(3,30) 4.740, p 0.016).
Figure 3A shows that the effect of 0.5 mg/kg peaked 10–20 min
postadministration and fell off more sharply thereafter. There was
no indication of any residual effect of scopolamine when LMA was
reexamined24h later (largestF(2,30)1.640,p0.211) for themain
effect of drug (data not shown).
Experiment 4: scopolamine infusion in mPFC in the
appetitive procedure
Histology
In total, three rats were excluded because the cannula tips were
misplaced. Two rats with placements on the borderline of ILwere
retained in the analyses. This left a final sample size of 61 (n 
8–12/cell: 11 Sal-2 s; 11 Sal-10 s; 8 IL-2 s; 9 IL-10 s; 12 PL-2 s; 10
PL-10 s). As shown in Figure 4A, there was little evidence of
gliosis at the cannula tip. Figure 4B illustrates the full range of
cannula placements included in the study.
ITI responding
As was the case in Experiment 2 (after systemic administration),
therewas no overall effect of scopolaminemicroinfusions in IL or
PL (F(2,55) 0.067, p 0.936). An interaction between infusion
Table 1. Mean total nose-poke responding in Experiments 2 and 4
2 s ISI 10 s ISI
Experiment 2
Saline
Scopolamine,
mg/kg, i.p.
Saline
Scopolamine,
mg/kg, i.p.
0.1 0.5 0.1 0.5
Day 1 8.545 1.442 5.083 1.362 5.167 1.507 15.500 2.445 12.833 1.882 17.667 4.302
Day 2 23.909 1.703 10.667 2.775 7.250 2.669 33.583 8.685 12.333 2.261 11.083 2.675
Day 3 31.182 2.040 19.917 2.832 12.750 3.527 49.000 10.708 16.750 2.273 16.083 4.719
Day 4 32.909 1.975 22.000 2.840 13.167 2.928 56.333 12.154 20.667 5.755 13.917 3.349
Experiment 4
Saline
Scopolamine,
0.075g in 0.5l/side
Saline
Scopolamine,
0.075g in 0.5l/side
IL PL IL PL
Day 1 4.364 1.357 2.625 1.009 3.000 1.141 9.667 2.845 12.600 2.849 13.714 2.653
Day 2 12.545 2.060 5.875 3.204 4.167 1.471 10.667 3.308 8.200 2.235 6.071 1.862
Day 3 21.182 1.672 10.750 3.759 11.167 3.263 18.750 3.810 7.778 2.087 5.714 1.203
Day 4 24.909 3.543 12.875 3.948 18.000 3.382 23.000 6.438 4.667 1.236 2.300 0.651
Data are shown as mean SEM.
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and days (F(6,165) 2.433, p 0.028) was independent of trace.
Figure 2Ca shows the 5 s ITI just preceding the 5 s CS presenta-
tions for direct comparisonwith subsequent CS andUS respond-
ing. As can be seen in the figure, the response rates in the 5 s ITI
immediately pre-CS were very low and unsuitable for ANOVA.
CS responding
The overall effect of scopolamine infusion (F(2,55)  5.444, p 
0.007) was to reduce responding during CS presentations. Acquisi-
tion was reflected in a days-by-trace interaction (F(3,165)  16.413,
p 0.001). Importantly a significant effect of scopolamine infu-
sionwas shown in the linear trendof the 3-way interaction (F(2,55)
3.752, p 0.030). Figure 2Cb shows that the difference over the
4 d of testing with respect to trace arose because the acquisition
functions in the 2 s trace groups infused in IL and PL mPFC
subregions were depressed. Follow-up analysis restricted to the
2 s trace group also showed a significant interaction between days
and infusion (F(6,84) 2.415, p 0.033). Therewas no such effect
in the 10 s trace group (F(6,81) 0.830, p 0.550). Day-by-day
analyses of CS responding confirmed that the effect of infusion
developed by day 3 (F(2,28)  4.081, p  0.027) and was also
significant on day 4 (F(2,28)  4.949, p 
0.014), whereas there was no such an ef-
fect of infusion on day 1 (F(2,28)  0.133,
p  0.876) or day 2 (F(2,28)  1.319, p 
0.283). On day 3, the main effect of infu-
sionwas due to a difference between saline
and both IL- and PL-infused animals
(saline vs IL, p  0.021, saline vs PL, p 
0.020). On day 4, the main effect of infu-
sion was due to a difference between the
saline and IL groups only (saline vs IL, p
0.040).
US responding
In contrast, there was no effect of scopol-
amine infusion on responding in the 5 s
when foodwasdelivered (maximumF(2,55)
2.718, p 0.075; Fig. 2Cc).
ISI responding: 2 s trace group
There was amain effect of infusion (F(2,28)
4.026,p 0.029). Scopolamine infusion in
IL (p  0.019) and PL (p  0.035) re-
duced responding in the 2 s ISI relative to
the level of responding seen in the saline
group. As shown in Table 1, this effect was
seen regardless of infusion site because the
scopolamine groups did not differ (p 
0.708).
ISI responding: 10 s trace group
The same overall pattern of results was
seen in the 10 s trace. There was a main
effect of infusion (F(2,27)  4.718, p 
0.017), which arose because scopolamine
infusion in IL (p  0.046) and PL (p 
0.006) overall reduced responding in the
ISI relative to the level of responding seen
in the saline group, regardless of infusion
site because the scopolamine groups did
not differ (p 0.447). There was an effect
of infusion by days in the 10 s trace group
(F(6,81)  4.843, p  0.001), which was
also clear in the linear trend (F(2,27) 
6.527, p 0.005). Respondingwithin the 10 s trace increased over
the 4 d of testing in the saline-infused group, but decreased over
the 4 d of testing in the IL and PL infusion groups (Table 1).
However, there was no effect of scopolamine infusion on the
distribution of responding within the trace interval in that there
were no interactions between infusion and bins (maximum F(24,324)
1.168, p 0.269).
Extinction tests
There was a significant interaction between trace and infusion (at
the conditioning stage) for both CS (F(2,58)  4.080, p  0.022)
and post-CS (F(2,58)  5.898, p  0.005) measures of magazine
activity during and after the tone tests. However, there was no
effect of prior infusion in the ITI for the tone tests (F  1).
Expectation of food was higher in the 2 s than the 10 s trace-
conditioned rats treated previously with saline. This difference by
trace group was attenuated or even reversed in rats that had been
conditioned after infusion of scopolamine in IL or PL. Therewere
no differences by prior infusion on any measures of responding
taken during the light extinction tests (maximum F(2,58)  1.011,
p 0.370).
Figure 3. Effect of systemic injections of scopolamine (i.p.) on spontaneous activity. The rats were habituated to the activity
chambers for 30 min before any drug treatment. Locomotor activity was then monitored for an additional 90 min. Error bars
indicate SEM. Asterisks indicate a significant difference compared with saline with *p 0.05, **p 0.01, ***p 0.0001.
A, Spontaneous activity in rats in Experiment 3 after being injectedwith saline or scopolamine at 0.1 or 0.5mg/kg (n 11 rats per
group).B, Spontaneous activity in rats in Experiment 5 after infusion of saline or scopolamine (0.075g in 0.5l/side) in PL or IL
(n 6–8 rats per group).
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Experiment 5: scopolamine infusion in
mPFC and locomotor activity
Scopolamine infusion in mPFC and loco-
motor activity were tested in a subset of
the rats used in Experiment 4, counterbal-
anced for previous PL–IL infusion condi-
tion. One rat could not be tested due to
equipment failure and one was subse-
quently excluded on histological grounds,
leaving a final sample size of 22 (n 6–8/
cell). There was no effect of infusion
condition-to-be on LMA measured dur-
ing the30min testdayhabituation(F(2,19)
1.823, p 0.189). In contrast to the effects
of scopolamine infusion on magazine ac-
tivity, LMAwas increased (F(2,19) 4.673,
p 0.022), significantly so in rats receiving
the IL infusion(p0.008) (Fig. 3B).ThePL
and IL infusion groups were also signif-
icantly different from each other (p 
0.036). The interaction between infusion
group and blocks was significant (F(16,152)
1.748, p 0.043).
Discussion
Experiment 1 used an established CER
procedure and a 10 s trace interval suitable
to test for conditioning impairment after
treatment with the muscarinic ACh an-
tagonist scopolamine (0.1 and 0.5 mg/kg,
i.p.). There was some apparent reduction
in contextual conditioning measured at the reshape stage of the
procedure. However, the results showed no effect of either dose
on either 10 s trace conditioning or in the delay conditioning
controls. In principle, scopolamine might have altered uncondi-
tioned responses to tone or shock and thus obscured effects on
trace conditioning. However, any such unconditioned effects
would be expected to be equivalent across behavioral conditions
and in this sense controlled for.We were interested in differences
by trace interval and there was none.
In other aversively motivated procedures, scopolamine has
been reported previously to reduce trace conditioning (Kaneko
and Thompson, 1997; Hunt and Richardson, 2007) and mPFC
has been shown to be an important substrate of AChmodulation
of trace conditioning (Flesher et al., 2011; Chen et al., 2014). The
present procedure was different from that adopted by Hunt and
Richardson (2007) in that we used a fixed rather than adjusted
duration CS for the delay conditioning control. However, the CS
duration used in the present study was fixed relatively long (at
10 s rather than the 5 s which is typically used in our laboratory
for the CER variant) and should have contributed to the working
memory load in the trace conditioned group.
In Experiment 2, systemic scopolamine impaired appetitive
conditioning at a 2 s trace interval. This effect was demonstrated
as reduced responding during presentations of the CS and during
the ISI. There was no such effect on responding during food US
responding or in the ITI. Moreover, in the Experiment 3 tests of
LMA, the same scopolamine treatments dose relatedly increased ac-
tivity. Experiment 4 and 5 tested the effects ofmicroinfusion of sco-
polamine (0.075g in 0.05l/side) in IL versus PL regions ofmPFC
in the same appetitive trace and LMA procedures. As per the effects
of systemic scopolamine, trace conditioning was impaired at the 2 s
trace (shown as reduced responding), whereas LMA was increased
after infusion inILmPFC.These results thuspoint to the importance
of cholinergicmodulation inmPFC for trace conditioning and show
that this effect cannot be attributed to reduced activity.
However, contrary to expectation (Gilmartin and McEchron,
2005; Gilmartin et al., 2014), we did not find evidence for functional
differentiationbetweenPLand ILmPFCmediatedbyactionatmus-
carinic receptors. The same effect of scopolamine was seen after in-
jection at either set of coordinates. The possibility that this lack of
difference may relate to diffusion radius is discussed below.
Selectivity of scopolamine effects
Asamuscarinic receptorantagonist, scopolamine isnonselectivebut
nonetheless widely used to assess the role ofmuscarinic receptors in
learning and memory (Klinkenberg and Blokland, 2010; Hasselmo
and Sarter, 2011). In the present study, the effects of scopolamine
point to the importance of muscarinic receptors inmPFC in appet-
itive conditioning to aCS presented at a trace interval. However, the
behavioral specificity, pharmacological resolution, and neuroanat-
omical selectivity of the findings should be considered.
Scopolamine effects ondelay conditioningwere not examined in
the appetitive procedure used in Experiments 2 and 4 and cannot be
excluded. However, there was no indication that the results were
confounded by nonspecific behavioral effects. As shown in Figure 2,
direct effects of scopolamine on responding in the ITI andwhen the
US was delivered during the acquisition stage showed a different
profile to those seen on CS responding. Moreover, treatment with
scopolamine increased LMA in Experiments 3 and 5. Therefore, the
reduced CS responding observed in the present study cannot be
attributed to generally reduced activity under scopolamine.
In addition to the acknowledged lack of more selective
muscarinic antagonists (Klinkenberg and Blokland, 2010), mi-
crodialysis studies have shown that the presynaptic actions of
muscarinic antagonists can be sufficient to increase the availabil-
Figure4. Histological verificationof cannulaplacements for rats used in Experiments 4 and5.A, Photographof a representative
placement illustrating the area around the injection. There is relatively little indication of gliosis as a result of the microinfusions.
B, Approximate locations of infusion cannula tips in the prelimbic (gray dots) and infralimbic (black dots) subregions of themPFC.
Placements are shownon coronal plates adapted fromPaxinos andWatson (1998),withnumbers indicatingdistance frombregma
in millimeters.
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ity of ACh in hippocampus (Dudar, 1977; Nilsson et al., 1990;
Newman and Gold, 2016). Consistent with potentially opposing
effects on ACh function, LMA can be increased or decreased after
treatment with scopolamine (Klinkenberg and Blokland, 2010).
Peripheral treatment with scopolamine at 0.15mg/kg is sufficient
to increase hippocampal ACh reliably. However, because this
effect peaks only 40 min after injection (Newman and Gold,
2016), it is unlikely to account for the behavioral findings of the
present study, which, as shown in Figure 3, were consistent over
the 60 min test sessions. With respect to its timeframe of action,
Experiment 3 also provided evidence that the behavioral effects of
scopolamine were of 24 h duration (because there was no re-
sidual effect of prior scopolamine treatment on the following
day). In Experiment 2, impaired expression of trace conditioning
was confirmed in extinction tests conducted 24 h later, at which
point direct effects of scopolamine on activity can be excluded.
We cannot exclude the possibility of some confounded residual
effect on activity in Experiment 4. The brain elimination half-life
may be longer (Ali-Melkkila¨ et al., 1993) and, in the present
study, we observed longer-lasting effects of scopolamine on LMA
after infusion into IL (compared with the LMA seen after sys-
temic injection at 0.1 mg/kg). Although the effect of systemic
scopolamine on activity dropped off over the 90 min LMA test
session, the hyperactivity after infusion in IL was maintained.
With respect to the neuroanatomical selectivity of the micro-
infusion procedure, the expected diffusion radius of a 0.5 l in-
jection is 1 mm (Allen et al., 2008). However, the minimally
pharmacologically active concentrations (at the outer limits of
the diffusion radius) are unknown, so the best criterion to deter-
mine spread has to be functional (Edeline et al., 2002). In the
present study, the fact that therewas somedifference in the effects
of scopolamine in IL versus PL on LMA (in that there was no
significant effect of scopolamine on LMA at the coordinates used
to target PL) suggests that functional differentiation of IL and PL
was achieved with the doses in use.
Implications of the role of mPFCmuscarinic receptors in
trace conditioning
The results of the present study suggest that muscarinic receptors
within the PL–IL mPFC are important for trace conditioning.
This finding is broadly consistent with a variety of other studies
showing the effects of scopolamine (Wirsching et al., 1984; Klinken-
berg and Blokland, 2010), specifically scopolamine in PFC on as-
pects of working memory (Granon et al., 1995; Chudasama et al.,
2004; Barker and Warburton, 2009; Hasselmo and Sarter, 2011;
Major et al., 2015). As a simple associativemeasure ofworkingmem-
ory, trace conditioning is an established model of hippocampal-
dependentmemory function (Sweatt, 2004). The model has good
validity in that the deleterious effects of neurodevelopmental
insult can bemitigated by nutritional supplementation with cho-
line to improve cholinergic neurotransmission (Thomas and
Tran, 2012). Trace conditioning has also been suggested to pro-
vide a behavioral model of age-related decline (Knuttinen et al.,
2001; McEchron et al., 2004; Moyer and Brown, 2006; Cheng et
al., 2010). Therefore, the further delineation of its neuropharma-
cological substratesmay suggest new targets to counteract themem-
ory loss of aging (Levey, 1996; Davis et al., 2010; Hasselmo and
Sarter, 2011).
The finding that the effects of systemic scopolamine were re-
produced bymicroinfusion inmPFC is consistent with the earlier
identified role of mPFC in trace conditioning (Kronforst-Collins
andDisterhoft, 1998;Weible et al., 2000, 2003;McLaughlin et al.,
2002; Takehara-Nishiuchi et al., 2005) and further delineates the
neuromodulatory role of ACh. With respect to the wider litera-
ture, our findings are also consistent with evidence pointing to
the role of ACh in the attentional aspects of short-term memory
(Hasselmo and Sarter, 2011; Klinkenberg et al., 2011) and con-
ventional tests of working memory that require flexible choice
responding (Graef et al., 2011).
Importantly, we also present evidence that the demonstration of
neuromodulatory effects may depend on the trace interval and/or
procedural variant in use. Differences due to the trace interval or ISI
are in practice difficult to distinguish from other procedural differ-
ences such as the number of learning trials and the ITI for tasks,
which aremotivated appetitively rather than aversively (Pezze et al.,
2016). Regardless of the underlying mechanism, we have found ev-
idence that procedural differences set boundary conditions for the
demonstration of scopolamine effects on trace conditioning.
The role of mPFC is consistent with other evidence pointing to
the importance of muscarinic ACh regulation of aspects of mPFC
function (Santini et al., 2012), including workingmemory (Granon
et al., 1995; Chudasama et al., 2004; Barker and Warburton, 2009;
Major et al., 2015). However, we submit that this role is likely sup-
ported by a wider network of distributed mechanisms (Sarter et al.,
2005; Egorov et al., 2006; Esclassan et al., 2009;Hasselmo andSarter,
2011; Baysinger et al., 2012), including cholinergic projections to
perirhinal cortex (Bang and Brown, 2009) and the septohippocam-
pal system(Givens andOlton, 1995; Seeger at al., 2004;Raybuck and
Gould, 2010; Newman and Gold, 2016).
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